MARKET

PBM

PBM

Psyence Biomedical Ltd.
NASDAQ
1.760
-0.050
-2.76%
After Hours: 1.770 +0.01 +0.57% 19:41 12/05 EST
OPEN
1.810
PREV CLOSE
1.810
HIGH
1.850
LOW
1.760
VOLUME
61.93K
TURNOVER
--
52 WEEK HIGH
62.72
52 WEEK LOW
1.410
MARKET CAP
3.29M
P/E (TTM)
-3.4618
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at PBM last week (1124-1128)?
Weekly Report · 4d ago
Psyence Biomedical announces psilocybin longevity research program
TipRanks · 11/25 12:15
Psyence BioMed Launches Psilocybin Longevity Research Program
Reuters · 11/25 12:11
Weekly Report: what happened at PBM last week (1117-1121)?
Weekly Report · 11/24 10:32
Psyence BioMed Expands Ibogaine Operations in Africa with Strategic Investment
TipRanks · 11/21 22:53
Psyence BioMed Takes Minority Stake in PsyLabs to Boost African Ibogaine Operations
Reuters · 11/21 22:18
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 11/21 12:05
Why Intuit Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Benzinga · 11/21 09:41
More
About PBM
Psyence Biomedical Ltd is a multi-asset, vertically integrated biopharmaceutical company specializing in psychedelic-based therapeutics. The Company is focused on developing nature-derived (non-synthetic) psilocybin-based psychedelic medicine. It is dedicated to addressing unmet mental health needs, particularly in palliative care. Its ongoing Phase IIb psilocybin clinical trial in Australia focuses on adjustment disorder in patients diagnosed with cancer.

Webull offers Psyence Biomedical Ltd stock information, including NASDAQ: PBM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PBM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PBM stock methods without spending real money on the virtual paper trading platform.